Epstein-Barr virus sustains tumor killers (Q45388862)

14 December 2017

Epstein-Barr virus sustains tumor killers (English)

1 reference

14 December 2017

1 reference

Richard J O'Reilly

1

1 reference

PubMed ID

18989276

14 December 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

14 December 2017

1 reference

14 December 2017

14

1 reference

14 December 2017

11

1 reference

14 December 2017

1148-1150

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1108-1148

14 December 2017

0 references

cites work

Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

Targeting tumours with genetically enhanced T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

inferred from DOI database lookup

7 January 2021

based on heuristic

Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

inferred from DOI database lookup

7 January 2021

based on heuristic

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

1 reference

https://api.crossref.org/works/10.1038%2FNM1108-1148

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM1108-1148

1 reference

PubMed ID

18989276

Dimensions Publication ID

14 December 2017

0 references

1 reference

PubMed ID

18989276